Our work to improve the quality and efficiency of clinical trials goes beyond the U.S. borders. Recently, CTTI conducted research to help inform the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) as it revises ICH E6 Good Clinical Practice (GCP).
Through a global, multi-stakeholder survey with 327 research professionals from 154 countries, in-depth interviews, and a public open comment period, CTTI determined that the areas requiring the most focus pertained to sponsors, essential documents, and investigators. This – along with co-hosting a public event with the FDA – is helping the ICH in its efforts to improve various topics within GCP.
Role![]() |
Name | Affiliation |
---|---|---|
Project Manager | Pamela Tenaerts | Clinical Trials Transformation Initiative |
Social Science Lead | Amy Corneli | Clinical Trials Transformation Initiative |
Team Member | Lawrence Calais | Department of Veterans Affairs |
Team Member | Jiyoung Choi | Northwell Health |
Team Member | Fred Feldstein | Johnson & Johnson/Janssen |
Team Member | Pamela Gonzalez | Department of Veterans Affairs |
Team Member | Patricia Hurley | American Society of Clinical Oncology |
Team Member | Ji-Eun Kim | Northwell Health |
Team Member | Martin Landray | University of Oxford |
Team Member | Peter Marks | Merck & Company, Inc |
Team Member | Sarah Mizrahi | Medidata Solutions |
Team Member | Theresa Mullin | Food and Drug Administration/CDER |
Team Member | Janette Panhuis | Population Health Research Institute-McMaster University |
Team Member | James Riddle | Quorum Review IRB |
Team Member | Michele Russell-Einhorn | Advarra |
Team Member | Maryam Sadat | Amgen Inc |
Team Member | Fergus Sweeney | European Medicines Agency |
Team Member | Melissa Bomben | Syneos Health |